Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer
Condition(s):Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:February 20, 2013Completed